top of page


How a 30-Bed Nursing Home in Tier-2 India Competes With a 300-Bed Hospital on Google Without Spending ₹10 Lakh on Ads
The large hospital chain has capital, brand and a marketing team. The nursing home has something far more valuable in local search, if it knows how to use it. I want to set something straight before we begin. The 30-bed nursing home is not losing to the 300-bed chain hospital because the chain has better doctors or because the patients want a bigger building and it's certainly not losing because the chain is providing better care. It's losing because the chain is easier to fi
Jul 1


Aggregator Trap: Why Diagnostic Labs Are Losing 40% of Their Walk-Ins to Portals And the AEO Playbook to Win Them Back
Listing on PharmEasy, Tata 1mg and Practo feels like distribution. It is actually displacement. Here is how to tell the difference and what to do about it. Let's start with a number that most diagnostic lab owners don't want to look at directly. When a patient books a thyroid panel through Tata 1mg or PharmEasy, the lab gets the sample, the lab does the work and the lab delivers the report. Then the aggregator takes between 20 and 40% of the transaction value in commissions,
Jun 25


Why IVF Clinics in India Are Spending ₹2 Lakh on One Patient Acquisition — How to Cut That Number in Half
The IVF patient researches for months before she ever calls you. Your marketing is probably starting on day 89. I want to tell you about a conversation I had with an IVF clinic founder in Tier-2 India last quarter. She had just reviewed her Q1 numbers and her cost per qualified lead (CPL) was ₹2,200 with a 14% consultation-to-conversion cycle. The average spend to acquire one IVF patient who actually completed a cycle was approximately ₹1.8 lakh. She wasn't unhappy with the n
Jun 22
bottom of page

